Genocea Biosciences, Inc. Commences Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Genocea Biosciences (GNCA) Prices 5.45M Common Share Offering at $8.25/Share
March 12, 2015 8:58 AM EDTGenocea Biosciences (NASDAQ: GNCA) announced the pricing of its public offering of 5,454,545 shares of its common stock at a public offering price of $8.25 per share, before underwriting discounts. In addition, Genocea has granted the underwriters a 30-day option to purchase up to an... More
Genocea Biosciences (GNCA) Plans Common Stock Offering
March 11, 2015 4:22 PM EDTGenocea Biosciences (NASDAQ: GNCA) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of this proposed offering, Genocea intends to grant the underwriters a 30-day option to purchase up to an additional... More
